Roche gets Swiss approval for skin cancer drug
ZURICH (Reuters) - Swiss drugmaker Roche Holding AG has received Swiss approval for Erivedge, the first medicine for people with advanced forms of basal cell carcinoma, the most common skin cancer.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Basal Cell Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Health | Skin | Skin Cancer